Mercer Capital Advisers’s Insmed INSM Stock Holding History

Mercer Capital Advisers’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-150	Closed	-$3K	–	292
2015 Q1	$3K	Hold	150	–	–	﹤0.01%	287
2014 Q4	$2K	Buy	+150	New	+$2.13K	﹤0.01%	284

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Mercer Capital Advisers's INSM Position: Q2 2015 in Review

Mercer Capital Advisers sold out of Insmed (INSM) in Q2 2015, closing a stake of 150 shares — an estimated $3K sold.

Mercer Capital Advisers first reported a position in INSM in Q4 2014 and held it in 2 quarters. The position peaked at $3K in Q1 2015. 116 funds tracked by Wall St. Rank hold INSM as of Q2 2015.

Mercer Capital Advisers reported no remaining Insmed position as of Q2 2015 after selling out during the quarter.
Mercer Capital Advisers sold 150 Insmed shares in Q2 2015, an estimated $3K.
Mercer Capital Advisers first reported a position in Insmed in Q4 2014 and held it in 2 quarters.
Mercer Capital Advisers's Insmed position peaked at $3K in Q1 2015.
116 funds tracked by Wall St. Rank held Insmed as of Q2 2015.

Based on Mercer Capital Advisers's 13F filing for Q2 2015, filed 27 Jul 2015.